Biblio Discovery — Demo Discovery Service

14 results for "Jane I Grove"

Showing 1–14 · 0.24 seconds · RSS

  1. Journal Article Full text

    A role for the tfs3 ICE-encoded type IV secretion system in pro-inflammatory signalling by the Helicobacter pylori Ser/Thr kinase, CtkA

    Maher N. Alandiyjany; Nicola J. Croxall; Jane I. Grove et al.

    PLOS ONE, Vol. 12 No. 7 · 2017 · English · PLOS Scopus

    Two distinct type IV secretion systems (T4SSs) can be identified in certain Helicobacter pylori strains, encoded on mobile genetic elements termed tfs3 and tfs4. Although their function remains unknown, both have been implicated in clinical outcomes of H. pylori infection. Here we provide evidence…

    Also available at: DOAJ

  2. Journal Article

    Monozygotic twins with NASH cirrhosis: cumulative effect of multiple single nucleotide polymorphisms?

    Jane I. Grove; Mark Austin; Jeremy Tibble et al.

    Annals of Hepatology, Vol. 15 No. 2 · 2016 · English · DOAJ Scopus

    Multiple genetic and environmental factors interact to determine an individual’s predisposition to non-alcoholic fatty liver disease and its phenotypic characteristics. Association studies have found a number of alleles associated with the development of non-alcoholic steatohepatitis. Our aim was…

  3. Journal Article

    The development of a food-group, tree classification method and its use in exploring dietary associations with metabolic dysfunction-associated Steatotic liver disease (MASLD) and other health-related outcomes in a UK population

    Amina A. Alawadi; Amrita Vijay; Jane I. Grove et al.

    Metabolism Open, Vol. 25 · 2025 · English · DOAJ

    Background: Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) affects up to one in five people in the UK, with persistent overeating and a sedentary lifestyle being significant risk factors. Exploring dietary patterns at a food level is a novel approach to understand associations…

  4. Journal Article

    Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis

    Stuart Astbury; Edmond Atallah; Amrita Vijay et al.

    Gut Microbes, Vol. 11 No. 3 · 2020 · English · DOAJ Scopus

    There is increasing evidence for the role of gut microbial composition in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Nonalcoholic steatohepatitis (NASH) is the most serious form of NAFLD where inflammation causes liver damage that can progress to cirrhosis. We have characterized…

  5. Journal Article

    Gut Microbial Profile Is Associated With Residential Settings and Not Nutritional Status in Adults in Karnataka, India

    Ojasvi Mehta; Leeberk Raja Inbaraj; Stuart Astbury et al.

    Frontiers in Nutrition, Vol. 8 · 2021 · English · DOAJ Scopus

    Undernutrition is a leading contributor to disease and disability in people of all ages. Several studies have reported significant association between nutritional status and gut microbiome composition but other factors such as demographic settings may also influence the adult microbiome. The…

  6. Journal Article

    Reliable computational quantification of liver fibrosis is compromised by inherent staining variation

    Stuart Astbury; Jane I Grove; David A Dorward et al.

    The Journal of Pathology: Clinical Research, Vol. 7 No. 5 · 2021 · English · DOAJ Scopus

    Abstract Biopsy remains the gold‐standard measure for staging liver disease, both to inform prognosis and to assess the response to a given treatment. Semiquantitative scores such as the Ishak fibrosis score are used for evaluation. These scores are utilised in clinical trials, with the US Food and…

  7. Journal Article Full text

    Biomarkers of Type IV Collagen Turnover Reflect Disease Activity in Patients with Early-Stage Non-Alcoholic Fatty Liver (NAFL)

    Ida Lønsmann; Jane I. Grove; Asma Haider et al.

    Biology, Vol. 12 No. 8 · 2023 · English · DOAJ Scopus

    Background: Identification of progressive liver disease necessitates the finding of novel non-invasive methods to identify and monitor patients in need of early intervention. Investigating patients with early-liver injury may help identify unique biomarkers. Early-liver injury is characterized by…

  8. Journal Article

    PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease

    Mette J. Nielsen; Grace E. Dolman; Rebecca Harris et al.

    JHEP Reports, Vol. 5 No. 6 · 2023 · English · DOAJ Scopus

    Background & Aims: Fibroblast activity is a key feature of fibrosis progression and organ function loss, leading to liver-related complications and mortality. The fibrogenesis marker, PRO-C3, has been shown to have prognostic significance in relation to fibrosis progression and as a treatment…

  9. Journal Article Full text

    The impact of pectin supplementation on systemic inflammation pathways, gut microbiome, and metabolic health in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A study protocol for a randomised controlled trial

    Noor Kifah Al-Tameemi; Jane I. Grove; Caroline L. Hoad et al.

    PLOS One, Vol. 21 No. 7 · 2026 · English · PLOS Scopus

    Background: Metabolic dysfunction–associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease, affecting over 30% of adults worldwide. Emerging evidence suggests that dietary fibre, particularly pectin, may improve metabolic health by modulating inflammation, gut…

  10. Journal Article

    Identification and characterisation of a rare MTTP variant underlying hereditary non-alcoholic fatty liver disease

    Jane I. Grove; Peggy C.K. Lo; Nick Shrine et al.

    JHEP Reports, Vol. 5 No. 8 · 2023 · English · DOAJ Scopus

    Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is a complex trait with an estimated prevalence of 25% globally. We aimed to identify the genetic variant underlying a four-generation family with progressive NAFLD leading to cirrhosis, decompensation, and development of hepatocellular…

  11. Journal Article

    Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans

    Kodihalli C. Ravindra; Vishal S. Vaidya; Zhenyu Wang et al.

    Nature Communications, Vol. 14 No. 1 · 2023 · English · DOAJ Scopus

    Diagnosis of rare, unpredictable, drug-induced liver injury (DILI) is a significant challenge for patients, clinicians, and drug development. Here, the authors discover, evaluate, and validate potential blood biomarkers to diagnose DILI and distinguish it from alternative causes of liver injury.

  12. Journal Article

    Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study

    Jane I. Grove; Camilla Stephens; M. Isabel Lucena et al.

    Diagnostic and Prognostic Research, Vol. 7 No. 1 · 2023 · English · DOAJ

    Abstract A lack of biomarkers that detect drug-induced liver injury (DILI) accurately continues to hinder early- and late-stage drug development and remains a challenge in clinical practice. The Innovative Medicines Initiative’s TransBioLine consortium comprising academic and industry partners is…